Dr Peter Sternhell discusses potential psychiatric complications of hepatitis C treatments containing pegylated interferon and ribavirin. Interferon can infrequently cause or worsen psychiatric conditions, including mood/depression/anxiety and other more serious affective and behavioural changes.
Cases are presented to illustrate how these conditions can be managed.
Target audience: General Practitioners, nurses and other managing clients on hepatitis C treatment.
CPD: Community HCV s100 Prescribers will receive 1 HCV CPD point for watching this webinar.
Type: Webinar (2014)
Funded by: NSW Health